HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe

NHIA Submits Comments to FDA Regarding At-Home Use Medical Technologies

September 5, 2023 by Laurie Watanabe

The National Home Infusion Association (NHIA) has submitted comments in response to a U.S. Food & Drug Administration (FDA) request on “Increasing Patient Access to At-Home Use Medical Technologies.”

In an Aug. 30 announcement, the NHIA said it was “applauding” the FDA for understanding “the importance of facilitating access to care in the home.”

Addressing her comments to FDA Commissioner Robert M. Califf, M.D., NHIA CEO/President Connie Sullivan, B.S. Pharm, said the NHIA appreciated recognition “of facilitating access to care in the home and for issuing this Request for Comment to promote expanded access to home use technologies.”

Sullivan added, “For more than 40 years, home infusion therapy (HIT) pharmacists and nurses have
collaborated to provide and administer intravenous (IV) and subcutaneous infused medications to
patients in their homes safely and effectively. Home infusion therapy keeps high-risk patients
with serious infections, heart failure, immune diseases, cancer, and other conditions out of
institutional settings and allows them to receive treatment at home. This proven model of care is
overwhelmingly preferred by patients, while also being cost-effective relative to institutional
care.”

Among the NHIA’s recommendations are to develop technologies that enable clinicians to remotely view, program, and download data from infusion pumps; to focus on how devices will be used by patients at home, rather than by clinicians; consider “an accelerated approval pathway for catheter lock combination solutions” that could prevent catheter-related bloodstream infections; to ensure that clinical trials include considerations for, as an example, drugs being administered in the home rather than in a clinical setting; change Medicare coverage for home infusion “so that infusion medications can be administered via disposable (non-durable) devices that are simpler for patients to use, compared to infusion pumps”; avoid drug labeling “that is prescriptive regarding method of administration or who administers the drug,” because such language can be restrictive to pharmacists and nurses working with patients who take drugs infused at home; and “consider the care setting when collecting data to evaluate quality.”

Read Sullivan’s full letter to the FDA here.

Related Articles Read More >

ASPEN, WCCC Launch Industry Surveys
Featuring the American Society for Parenteral and Enteral Nutrition and the Wound Care Collaborative Community.
AdaptHealth Reportedly Acquires WellSpan’s DME Business
WellSpan currently has more than 220 sites of care, including eight hospitals.
Quipt Home Medical Eyes Hospital Partnerships to Reignite Growth
BBB’s Latest Scam Warning Includes DME for Older Adults
The warning noted the potential for a “same or similar” Medicare denial in the future if beneficiaries don’t report receiving unnecessary equipment.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
continuum event
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe